Cinepazide Mesylate
甲磺酸桂哌齐特
Report date: 2022/12/08 17:42:48
Base Information
Drug NameCinepazide Mesylate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSihuan Pharmaceutical Holdings Group Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Sihuan Pharmaceutical Co LtdHainan Sihuan Cardiocerebral Vascular Medicine Research Institute Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A